Your browser doesn't support javascript.
loading
Long-term 23-year Global Post-marketing Safety Surveillance Review of Delayed Complications with a Supportive Hyaluronic Acid Filler for Infraorbital Hollow Rejuvenation.
Siperstein, Robyn; Cho, Younghoon; Hicks, Jessica.
Afiliação
  • Siperstein R; Dr. Siperstein is with the Siperstein Dermatology Group in Boynton Beach, Florida.
  • Cho Y; Dr. Cho is with Integrated Aesthetics in Spring, Texas.
  • Hicks J; Dr. Hicks is with Galderma Medical Affairs in Dallas, Texas.
J Clin Aesthet Dermatol ; 17(7): 50-51, 2024 Jul.
Article em En | MEDLINE | ID: mdl-39006808
ABSTRACT
HARES is a supportive (high G') HA filler with a low degree of water affinity (gel swelling) and modification (<1% BDDE) that has a well-established safety and efficacy profile in the literature, especially for infraorbital hollow (IOH) rejuvenation. To further support the safety of this product, a long-term review of delayed-onset adverse events of interest (DAEIs) related to HARES was conducted using reports from a global post-marketing safety surveillance database over the past 23 years. This review demonstrated low reporting frequencies of delayed-onset nodules and inflammatory events, establishing a long-term safety profile for HARES that supports its continued use in clinical practice, especially for IOH rejuvenation.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article